Parkinson's Disease Trial, Not Yet Recruiting NCT07656129 Sponsor: Zhengli Di Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07656129
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with idiopathic (naturally occurring, not caused by another condition) Parkinson's disease, confirmed by two neurologists using recognised Chinese diagnostic guidelines based on international Parkinson's diagnostic criteria.
  • People whose Parkinson's symptoms, when their medication is working, fall within a standard severity range known as Hoehn and Yahr stages 1 to 5.
  • People who score above 24 on a standard short memory and thinking test called the Mini-Mental State Examination (MMSE).
  • People whose Parkinson's medications have remained unchanged for at least one month before the trial begins.
  • People with no history of bone, joint, or muscle disorders, and no other conditions that could affect balance or walking, such as eye disorders.
  • People with no history of epilepsy, brain tumours, or other neurological conditions; no severe mental health conditions such as schizophrenia; and no long-term use of antipsychotic medications.
  • People aged between 40 and 80 years.
  • People who are able to participate in all assessments and the trial treatment, and who are willing to sign a written consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose parkinsonism is caused by another condition (secondary parkinsonism) or who have an atypical form of parkinsonism.
  • People who are currently taking anticholinergic medications (a type of medication that blocks certain nerve signals).
  • People who have a medical reason that prevents them from safely receiving non-invasive electrical nerve stimulation (confirm with trial site).
  • People who have received eTNS (external trigeminal nerve stimulation) treatment within the past six months.
  • People who have severe neurological, kidney, heart, liver, or other major health conditions.
  • People who are unable to complete the required assessments, or who are unwilling to provide written consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Zhengli Di
Registry
ClinicalTrials.gov
Start date
15 June 2026
Est. completion
15 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Dual-Task Cost (DTC); Mean Gait Speed(m/s); Mean Stride Length (m)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov